Clariant is to invest CHF 80 million to expand its Care Chemicals facility at Daya Bay in Huizhou, China, by the end of 2024. This will both add capacity for existing products and introduce new products in the pharmaceutical, personal care, home care and industrial sector.

Daya Bay, which has obtained the drug GMP certificate, is the first API site in China certified to produce polyethylene glycol Polyglykol 3350. More generally, it will become new global hub for Clariant’s healthcare business support.

IMCD has agreed agreement to acquire Shanghai Sanrise Industries & Development, a major distributor in China’s personal care markets. This will take place in two tranches: 70% now and the rest in 2025. Closing, subject to customary conditions and regulatory approval, is expected to take place in Q1 2023.

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes itself as a carbon capture and transformation (CCT) company. No commercial terms were disclosed.

Japan’s Kao Corporation has joined the $120 million venture previously announced by Genomatica and Unilever to scale and commercialise plant-based alternatives to palm kernel oil. The firm described this is as a key move towards meeting goals of becoming carbon-neutral by 2040 carbon-negative by 2050, by making responsibly sourced palm oil and derivatives a critical feedstock.

Dutch start-up RheoCube has opened up its first US office in the Cambridge Innovation Center in Boston to accelerate the commercial expansion there. Further new locations are planned, which will be announced later.

The company, which was built by scientific modellers, experimentalists and other experts within Electric Ant Lab, markets a cloud-based experimental research platform. This is claimed to offer R&D scientists “a digital and fully integrated research solution to test hypotheses, reduce costly trial-and-error and accelerate their research”.

Clariant has agreed to sell its global quaternary ammonium compounds to Global Amines Company, its Singapore-based 50-50 joint venture with Wilmar, for $113 million. Subject to regulatory approval and standard closing conditions, this is expected to close in 1H 2023.

BASF has signed a partnership, including a strategic equity investment, in Chinese firm Ingredi. Precise details were not disclosed but BASF said that this will enable Ingredi to extend its production facilities and that the two companies will work together to “identify new solutions and commercialise these to the global personal care market”.